CardiacSense announced today that it received FDA clearance for its CSF-3 watch for measuring a handful of vital signs. The watch measures beat-by-beat heart rate and oxygen saturation of arterial hemoglobin (SpO2). Caesarea, Isreal-based CardiacSense received CE mark approval for four indications for the watch in February 2021. That approval included continuous AFib monitoring and […]
CardiacSense
CardiacSense medical-grade watch wins CE mark for continuous Afib detection
CardiacSense today said it received CE mark approval for its medical-grade watch that remotely and continuously monitors atrial fibrillation and heart rate variability. The watch was approved for Afib detection and heart rate variability with continuous Photoplethysmography (PPG) and electrocardiogram (ECG). It allows for continuous, long-term, accurate and comfortable patient monitoring without the need to […]
